MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND--(Marketwire - November 27, 2007) - Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today updated shareholders at its Annual General Meeting on the Company’s Russian clinical trial, the status of its New Zealand clinical trial and commercialization plans.
